Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Oct 25;9(4):rkaf125.
doi: 10.1093/rap/rkaf125. eCollection 2025.

18F-FDG PET/CT discriminates whether rheumatoid arthritis patients are in ultrasound remission or not

Affiliations

18F-FDG PET/CT discriminates whether rheumatoid arthritis patients are in ultrasound remission or not

Charline Rinkin et al. Rheumatol Adv Pract. .

Abstract

Objectives: 18F-FDG PET/CT is used for cancer evaluation but can also quantify joint inflammation in RA. We evaluated its ability to identify patients in remission as defined by US.

Methods: Sixty RA patients underwent clinical, PET/CT and US evaluations (hands and wrists). For PET/CT, the maximum standardized uptake value (SUVmax) was determined. At the patient level, the highest SUVmax, number of PET-positive joints and cumulative SUVmax were recorded. US evaluation included gray-scale and power Doppler.

Results: At the joint level, SUVmax was significantly lower when the joint was in US remission (P < 0.0001). Receiver operating characteristics curves identified a threshold of 0.86 to define joint remission with a high positive predictive value of 95.2%. At the patient level, the highest SUVmax and cumulative SUV were significantly lower in patients in US remission (respectively P = 0.0023 and P = 0.045). The highest SUVmax threshold of 2.36 demonstrated a high negative predictive value of 92.9% for determining US remission. For the cumulative SUVmax threshold, the negative and positive predictive values for determining US remission were both 73%. In contrast, these PET/CT parameters did not discriminate if a patient is in clinical remission or not.

Conclusions: PET/CT can identify RA patients in remission as defined by US. We show that the highest SUVmax and cumulative SUV are the two discriminative PET/CT parameters able to determine whether a patient is in US remission. This provides an additional advantage of PET/CT as an objective tool to evaluate RA.

Keywords: 18F-FDG PET/CT; remission; rheumatoid arthritis; ultrasonography.

PubMed Disclaimer

References

    1. Legrand J, Kirchgesner T, Sokolova T, Vande Berg B, Durez P. Early clinical response and long-term radiographic progression in recent-onset rheumatoid arthritis: clinical remission within six months remains the treatment target. Joint Bone Spine 2019;86:594–9. - PubMed
    1. Brandt LLN, Schulze-Koops H, Hügle T et al. Radiographic progression in patients with rheumatoid arthritis in clinical remission or low disease activity: results from a Swiss National Registry (SCQM). J Clin Med 2024;13:7424. - PMC - PubMed
    1. Chen CC, Chen DY. The clinical utility of musculoskeletal ultrasound for disease activity evaluation and therapeutic response prediction in rheumatoid arthritis patients: a narrative review. J Med Ultrasound 2023;31:275–81. - PMC - PubMed
    1. Liu F, Li W, Zhu J et al. Predictive role of ultrasound remission for progressive ultrasonography-detected structural damage in patients with rheumatoid arthritis. J Investig Med 2022;70:391–5. - PubMed
    1. Filippou G, Sakellariou G, Scirè CA et al. The predictive role of ultrasound-detected tenosynovitis and joint synovitis for flare in patients with rheumatoid arthritis in stable remission. Results of an Italian multicentre study of the Italian Society for Rheumatology Group for Ultrasound: the STA. Ann Rheum Dis 2018;77:1283–9. - PubMed

LinkOut - more resources